NASDAQ: IOVA · Biotechnology
Over the past week, Iovance Biotherapeutics (IOVA) saw about 112 mentions across Reddit, X and news, and the read is an Adanos Hold. The crowd averages 56% bullish but is sharply divided: News runs 80% bullish while X sits at just 36%. Wall Street is more constructive, with 7 of 9 analysts rating IOVA a buy.
There is little buzz around IOVA this week and little agreement on direction, which is why it reads as a Hold.
Wall Street’s 78% buy share sits next to a crowd that ranges from X at 36% to News at 80%. No other tracker puts the two side by side.
9 analysts have weighed in: a Strong Buy consensus: 7 buy calls against 0 sell, with an average 12-month price target of $10.70.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits above the neutral line, momentum is cooling and the 3 sources disagree sharply, so the read is Hold rather than a clear buy or sell.
Analysts sit 22 points above the crowd average of 56%, the professionals are more constructive than retail. The split is inside the crowd: News reads 80% bullish while X sits at 36%, a 44-point spread that single-source trackers miss.
Over the 30-day window, Iovance Biotherapeutics (IOVA) buzz held moderate around 41.9 while the price drifted up 37.3% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 13.7M shares. Updated Sep 26, 2026. Over the last 7 trading days, IOVA gained 9.8%. Buzz activity in the recent week averaged 43.9 and was variable, swinging between 30.2 and 56.7. Recent volume is running above the 30-day average, suggesting heightened trading interest. Daily crowd sentiment leaned bullish on 19 of the 20 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for IOVA and 2110+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live IOVA sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Sep 26, 2026.
| Adanos signal | Hold |
|---|---|
| Analyst consensus | Strong Buy (7 / 2 / 0) |
| Crowd bullish (7d) | 56% |
| Avg price target | $10.70 |
| Most bullish source | News, 80% |
| Most bearish source | X, 36% |
| Sentiment spread | 44 pts |
| Mentions (7d) | 112 |
| Market cap | $4.89B |
| EPS · Beta | -$0.69 · 0.8 |
| Revenue (TTM) | $325M · -89% margin |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, Iovance Biotherapeutics (IOVA) currently carries an Adanos hold signal with 60/100 conviction. The current cross-source average reads 56% bullish across 3 active sources. Those sources contribute 112 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Iovance Biotherapeutics (IOVA) is fairly quiet with 29 mentions over the last 7 days; the 30-day context spans 12 tracked subreddits. The 7-day tone is 52% bullish; 3-day activity momentum is falling, suggesting cooling attention.
The crowd reads bullish on Iovance Biotherapeutics (IOVA), averaging 56% bullish across 3 tracked sources over the last 7 days. The two ends of the range are News at 80% bullish and X at 36%, a 44-point spread. On the professional side, 7 of 9 analysts rate IOVA a buy.
Of the 9 analysts covering Iovance Biotherapeutics (IOVA), 7 rate it a buy, 2 a hold and 0 a sell, for a strong buy consensus. The average price target is $10.70. That puts the street ahead of the crowd, which averages 56% bullish.
Iovance Biotherapeutics (IOVA)'s cross-source average is bullish at 56% bullish. Source readings are split: 2 sources lean bullish and 1 source leans bearish. Reddit reads 52% bullish, News reads 80% bullish and x coverage is the most negative at 36% bullish. The combined signal points to broad mixed pressure with 60/100 conviction.
The cross-source average is bullish for Iovance Biotherapeutics (IOVA) at 56% bullish. Source readings are split: 2 sources lean bullish and 1 source leans bearish. The most bearish reading is x at 36% bullish. 3-day activity momentum is falling on Reddit and News, while x activity is rising. The hold signal carries 60/100 conviction.
X is the dominant discussion channel with 78 mentions (70% of total volume). Reddit contributes 29 mentions and News contributes 5 mentions. The cross-source average is bullish at 56% bullish, while x is the only source with rising 3-day activity. Source readings are split: 2 sources lean bullish and 1 source leans bearish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. IOVA's hold signal at 60/100 conviction reflects a bullish cross-source average at 56% bullish. Source readings are split: 2 sources lean bullish and 1 source leans bearish. It is a research shortcut, not financial advice.
The IOVA sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Hold signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key